IBD patients not to stop immunosuppressive drugs due to Covid 19 fear: Experts
Patients of Inflammatory bowel disease on immunosuppression drugs should not stop taking their medications according to a new study. The risk of disease flare far outweighs the chance of contracting coronavirus. However these patients should follow CDC guidelines for at-risk groups: avoid crowds and limit travel.;
Written By : Hina Zahid
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2020-03-20 10:45 GMT | Update On 2020-03-20 10:46 GMT
Advertisement
Bethesda, Maryland -- A paper published today in Clinical Gastroenterology and Hepatology by clinicians at Icahn School of Medicine at Mount Sinai outlines key information gastroenterologists and patients with chronic digestive conditions need to know about COVID-19 or coronavirus.
Coronavirus is of particular concern for patients with inflammatory bowel disease (IBD) who may take immunosuppression drugs. The paper, published in a journal of the American Gastroenterological Association, provides clear guidance:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.